Inactive Instrument

Press Releases THERACLION N Euronext Paris

Equities

FR0010120402

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

27/03	Theraclion SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated with Sonovein as Part of the Fda- Approved Pivotal Study	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Theraclion Announces 2023 Financial Results and Continues Its Roadmap	27/03	BU
Theraclion : announces 2023 financial results and continues its roadmap	27/03	PU
Theraclion : Présentation AGM – 29 juin 2023	21/12	PU
Theraclion : Presentation AGM 29 juin 2023	24/23/24	PU
THERACLION : ANNOUNCES 2022 FINANCIAL RESULTS AND INFORMS ON THE COMPANY’S SHORT-TERM FINANCING	28/23/28	PU
THERACLION : SUCESSFULLY REPRESENTATED AT THE 8TH INTERNATIONAL SYMPOSIUM ON FOCUSED ULTRASOUND	14/22/14	PU
Theraclion : Last patient of first SONOVEIN® US study has been treated	17/22/17	PU
Theraclion : AGM 2022 Présentation	30/22/30	PU
Theraclion : Inside Information / Other news releases	24/22/24	PU
Theraclion : is deploying its scalable robotic platform SONOVEIN® in Europe	15/21/15	PU
Theraclion : results show strong recovery, allowing ambitious plans	23/21/23	PU
Theraclion : FDA approves the 1st trial with Theraclion’s vein therapy in the US	20/21/20	PU
Theraclion : Bernard Sabrier and Unigestion pass the 20% threshold, proof of confidence in the company’s development	10/21/10	PU
Theraclion : UVA Cancer Center to expand use of Theraclion’s HIFU system in cancer treatment research.	02/21/02	PU
Theraclion : In 2020, Theraclion has succeeded a crucial step for its technology.	23/21/23	PU
In 2020, Theraclion Has Succeeded a Crucial Step for Its Technology: Results Allow Further Expansion for the Next Two Years	22/21/22	BU
Theraclion : Strategy Is in Place for 2021 Despite the Impact of Covid-19 on Sales Revenues For 2020	19/21/19	BU
Theraclion : strategy is in place for 2021 despite the impact of Covid-19 on sales revenues for 2020	19/21/19	PU
Theraclion : Renewed Investor Confidence in Theraclion	17/20/17	BU
Theraclion : Positive and Differentiated Results for Theraclion’s Non-invasive Varicose Vein Treatment Technology Revealed at The 34th AVLS	21/20/21	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases THERACLION N Euronext Paris

Equities

FR0010120402

Press Releases

Filters